Transplant Surgery

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Transplants 82%
3. Kidney 72%
4. Kidney Transplantation 63%
5. Allografts 62%
6. Tissue Donors 52%
7. Living Donors 48%
8. Artificial Liver 38%
9. Transplantation 36%
10. Liver 34%
11. Hepatocytes 33%
12. Transplant Recipients 33%
13. Klatskin Tumor 26%
14. Antibodies 25%
15. Biopsy 24%
16. Pancreas Transplantation 22%
17. Graft Survival 21%
18. Isoantibodies 20%
19. Swine 18%
20. Survival 17%
21. Acute Liver Failure 16%
22. Tacrolimus 16%
23. Cholangiocarcinoma 15%
24. Fibrosis 14%
25. End Stage Liver Disease 14%
26. Pancreas 14%
27. Hepatocellular Carcinoma 13%
28. Liver Diseases 13%
29. Immunosuppression 12%
30. Glomerular Filtration Rate 12%
31. Therapeutics 11%
32. Sclerosing Cholangitis 11%
33. Mortality 10%
34. Sirolimus 9%
35. Organ Transplantation 9%
36. fumarylacetoacetase 8%
37. Incidence 8%
38. Recurrence 8%
39. Cell- and Tissue-Based Therapy 8%
40. Histology 8%
41. eculizumab 7%
42. Tyrosinemias 7%
43. Cyclosporine 7%
44. Wounds and Injuries 7%
45. Hypertension 7%
46. Mycophenolic Acid 7%
47. Mesenchymal Stem Cells 6%
48. Dendritic Cells 6%
49. Inflammation 6%
50. Serum 6%
51. Plasma Cells 6%
52. Obesity 6%
53. Immunosuppressive Agents 6%
54. Nephrectomy 6%
55. Psychology Rejection 5%
56. Dialysis 5%
57. Proteinuria 5%
58. Blood Group Antigens 5%
59. Liver Failure 5%
60. Renal Insufficiency 5%
61. HLA Antigens 5%
62. Liver Regeneration 5%
63. Hepacivirus 5%
64. Neoplasms 5%
65. Clinical Trials 5%
66. Equipment and Supplies 5%
67. Gene Expression 5%
68. Anti-Idiotypic Antibodies 5%